Effects of an operational multidisciplinary team on hospital antibiotic use and cost in France: a cluster controlled trial
- 219 Downloads
Objective The study objective was to evaluate the effectiveness of an operational multidisciplinary antibiotic team, including an infectious disease physician and a clinical pharmacist, in reducing the hospital antimicrobial consumption and costs. Setting The 1800-bed University Hospitals of Nancy (France). Method A cluster controlled ‘before-after’ study was performed. The intervention group comprised 11 medical and surgical wards in settings where the operational antibiotic team was implemented, and the control group comprised 6 wards without this operational team. The ‘before’ period (2005) preceded the implementation of the operational team in the intervention group and ‘after’ (July 2007 to June 2008) followed its full implementation. Main outcome measure We compared consumption of antibiotics overall and by therapeutic class (in defined daily doses per 1,000 patient days) and cost savings (in €) between ‘before’ and ‘after’ in both groups (control and intervention), using a mixed effect linear model. Results The overall consumption of antibiotics decreased after implementation of the operational team by 33.6% in the intervention group and by 3.3% in the control group (P = 0.003). Compared with the control group, the decrease in antibiotic use in the intervention group was significantly higher for various therapeutic classes (broad-spectrum penicillins, injectable fluoroquinolones, glycopeptides) and specific drugs (imipenem, ciprofloxacin, teicoplanin). For the same activity, the total cost savings were 14-fold higher in the intervention group. Conclusion Establishment of an operational multidisciplinary team may be an effective way to reduce hospital antibiotic use and cost, with a good acceptance rate among prescribers.
KeywordsMultidisciplinary team Antibiotics Consumption Costs Cost savings Cluster controlled trial France
We would like to thank all clinicians of the University hospitals of Nancy, and particularly those of the Brabois hospital who welcomed us to their ward.
No funding was obtained for this study.
Conflicts of interest
- 2.Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Projet ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis. 1999;29(2):245–52.PubMedCrossRefGoogle Scholar
- 8.Bantar C, Sartori B, Vesco E, Heft C, Saùl M, Salamone F, et al. A hospital wide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis. 2003;37(2):180–6.PubMedCrossRefGoogle Scholar
- 10.Ministry of Health and Ministry of Food, Agriculture and Fisheries, Denmark. Report from the European Union Conference on ‘The Microbial Threat’, Copenhagen Recommendations. Copenhagen, Denmark; 9–10 September 1998.Google Scholar
- 11.WHO. Overcoming Antimicrobial Resistance. World Health Organization Report on Infectious Diseases; 2000. Available from: http://who.int/infectious-disease-report/2000/index.html. Accessed December 2010.
- 12.Arrêté du 31 mars 1999 relatif à la prescription, à la dispensation et à l’administration des médicaments soumis à la réglementation des substances vénéneuses dans les établissements de santé, les syndicats interhospitaliers et les établissements médico-sociaux disposant d’une pharmacie à usage intérieur mentionnés à l’article L. 595-1 du code de la santé publique.Google Scholar
- 13.Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborative Center for Drug Statistics Methodology, Norwegian Institute of Public Health; 2007.Google Scholar